Heart scans could uncover silent damage in liver patients awaiting transplant
NCT ID NCT06327308
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This pilot study is testing whether cardiac MRI can detect and track heart muscle scarring in people with cirrhosis who are waiting for a liver transplant. Researchers want to see if inflammation from the liver disease affects the heart, and whether a transplant can reverse that damage. Sixty participants will undergo MRI scans before and after their transplant to monitor changes in the heart muscle.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cardiac MRI
- What this could lead to
- If successful, this could help doctors detect and monitor heart problems in people with cirrhosis, potentially improving care before and after liver transplant.
- What could go wrong
- This is a small pilot study with only 60 participants, so results may not apply to everyone. MRI scans can be uncomfortable and may not be suitable for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU Nancy - Hôpital de Brabois
RECRUITINGNancy, 54000, France
Contact
-
CHU Besancon - Hopital Minjoz
RECRUITINGBesançon, 25000, France
Contact
-
CHU Dijon - Hopital François Mitterrand
RECRUITINGDijon, 21000, France
Contact
-
CHU Strasbourg - Hopital de HautePierre
NOT_YET_RECRUITINGStrasbourg, 67000, France
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
- Scientists hunt for clues in body fluids to predict liver failure outcomes
- Blood transfusion strategy could be refined for liver patients
- Liver's Post-Meal secrets could unlock new fatty liver treatments
- Can eating only during an 8-10 hour window help liver cancer patients?
- New drug zanzalintinib tested for advanced liver cancer